Compumedics Limited
Research Compumedics Limited (CMP.AX) on Bullrun: market cap AUD 47.94M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCMP.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Market capAUD 47.94M
- Financial periodFY2024
- RevenueAUD 49.72M
- Revenue growth17.2%
- Net income-AUD 499.00K
- Free cash flow-AUD 847.00K
- Gross margin52.4%
Valuation Snapshot
latest market cap is AUD 47.94M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | AUD 49.72M | -AUD 499.00K | -AUD 847.00K | 52.4% | -0.01 | AUD 1.89M | AUD 8.57M | AUD 18.02M |
| FY2023 | AUD 42.41M | -AUD 6.12M | -AUD 4.36M | 50.9% | -0.03 | AUD 3.80M | AUD 16.69M | AUD 18.72M |
| FY2022 | AUD 37.76M | AUD 1.36M | AUD 418.00K | 51.2% | 0.01 | AUD 7.08M | AUD 12.34M | AUD 23.59M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | AUD 47.94M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Compumedics Limited
Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and associated technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. The company provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon HST; and Somté, an investigative tool. The company also offers neurology diagnostics, such as ONsight A.V.S.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Compumedics Limited's market cap?
Compumedics Limited's market capitalization is AUD 47.94M.
What does Compumedics Limited do?
Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and associated technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. The company provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon HST; and Somté, an investigative tool. The company also offers neurology diagnostics, such as ONsight A.V.S.